Clinical Trial Update: Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 trial of intravitreal microplasmin for uveitic macular edema; the study was terminated with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Microplasmin intravitreal administration (microplasmin)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Uveitis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-08-14